Compare VTAK & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTAK | FTEL |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.7M |
| IPO Year | 2018 | 2023 |
| Metric | VTAK | FTEL |
|---|---|---|
| Price | $2.05 | $2.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 269.9K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | ★ 65.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $730,000.00 | ★ $5,200,138.00 |
| Revenue This Year | $822.86 | N/A |
| Revenue Next Year | $168.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 82.96 | 16.42 |
| 52 Week Low | $1.49 | $2.35 |
| 52 Week High | $15.68 | $1,418.48 |
| Indicator | VTAK | FTEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 51.21 |
| Support Level | $2.05 | $2.96 |
| Resistance Level | $2.19 | $3.85 |
| Average True Range (ATR) | 0.14 | 0.36 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 4.67 |
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.